Second-generation irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs): A better mousetrap? A review of the clinical evidence
2012 ◽
Vol 83
(3)
◽
pp. 407-421
◽
2015 ◽
Vol 15
(8)
◽
pp. 988-1011
◽
2009 ◽
Vol 19
(8)
◽
pp. 2333-2337
◽
2006 ◽
Vol 1766
(2)
◽
pp. 217-229
◽
2012 ◽
Vol 42
(19)
◽
pp. 2937-2946
◽